Doxorubicin-induced cardiomyopathy treated with carvedilol

被引：44

作者：

Fazio, S ^{[1
]}

Palmieri, EA ^{[1
]}

Ferravante, B ^{[1
]}

Bone, F ^{[1
]}

Biondi, B ^{[1
]}

Sacca, L ^{[1
]}

机构：

[1] Univ Naples Federico II, Div Med Interna 3, Sch Med, Dept Internal Med, I-80131 Naples, Italy

来源：

CLINICAL CARDIOLOGY | 1998年 / 21卷 / 10期

关键词：

doxorubicin; cardiomyopathy; carvedilol;

D O I：

10.1002/clc.4960211017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Even today, heart failure due to doxorubicin-induced dilated cardiomyopathy seems to have a poor prognosis, as it is often irreversible and relatively unresponsive to standard medical treatment. This paper describes the first case of a patient complaining of severe symptoms of congestive heart failure due to doxorubicin-induced dilated cardiomyopathy unresponsive to standard medical treatment (digoxin, diuretics, and angiotensin-converting enzyme inhibitor), who showed complete clinical recovery and significant improvement of left ventricular dysfunction after carvedilol treatment. It also illustrates the possibility that carvedilol may be a first-choice drug for the treatment of this disease.

引用

页码：777 / 779

页数：3

共 9 条

[1] CARDIOPROTECTIVE EFFECTS OF CARVEDILOL, A NOVEL BETA-ADRENOCEPTOR ANTAGONIST WITH VASODILATING PROPERTIES, IN ANESTHETIZED MINIPIGS - COMPARISON WITH PROPRANOLOL
BRIL, A
SLIVJAK, M
DIMARTINO, MJ
FEUERSTEIN, GZ
LINEE, P
POYSER, RH
RUFFOLO, RR
SMITH, EF
[J]. CARDIOVASCULAR RESEARCH, 1992, 26 (05) : 518 - 525
[2] CHOEN M, 1982, ARCH INTERN MED, V142, P1570
[3] DOROSHOW JH, 1983, CANCER RES, V43, P460
[4] GIANNI L, 1983, REV BIOCHEM TOXICOL, P1
[5] The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
Packer, M
Bristow, MR
Cohn, JN
Colucci, WS
Fowler, MB
Gilbert, EM
Shusterman, NH
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21) : 1349 - 1355
[6] REVERSIBILITY OF SEVERE LEFT-VENTRICULAR DYSFUNCTION DUE TO DOXORUBICIN CARDIOTOXICITY - REPORT OF 3 CASES
SAINI, J
RICH, MW
LYSS, AP
[J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) : 814 - 816
[7] VANHOFF DD, 1979, ANN INTERN MED, V91, P710
[8] THE ANTHRACYCLINE ANTI-NEOPLASTIC DRUGS
YOUNG, RC
OZOLS, RF
MYERS, CE
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (03) : 139 - 153
[9] YUE TL, 1992, J PHARMACOL EXP THER, V263, P92

← 1 →